News

Events

Conferences

Clinical Research Management News

CRM Partners with ITT Corporation to Win a Part of the RDECOM Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Mission Support Contract (CMSC)

CRM has partnered with ITT Corporation (ITT) to win a part of the multiple-contract solicitation, “RDECOM CBRNE Mission Support Contract (CMSC) with the Edgewood Chemical, Biological Center. CMSC is a five-year IDIQ contract valued at $485,000,000 and is shared with nine other companies.

The Edgewood Chemical Biological Center’s Science and Technology expertise has protected the United States from the threat of chemical weapons since 1917. Since that time, the Center has expanded the mission to include biological materials and is today the nation’s premier authority on chemical and biological defense.

The Edgewood Center and associated facilities provides the full spectrum of basic research, engineering, and analysis of Warfighter systems from concept to capabilities. This solicitation required a broad requirement for services involving engineering, program and integration support, and research and technology support. ITT approached CRM last summer to partner with them in our areas of expertise, especially in biomedical research and molecular biology. ITT found especially impressive our research into antimicrobials and genomics, along with our defined abilities in microbiology and our work with biothreat organisms. CRM’s experience is especially strong in these areas because of what our fantastic employees do every day at USAMRIID and WRAIR, as well as our Clinical Solutions Division's involvement with NIAID.

CRM is looking forward to partnering with ITT in this endeavor.

Victoria Tifft, President and CEO of CRM Selected as a Top Ten Women Business Owner of Northeast Ohio for 2010

Victoria Tifft, President and CEO of Clinical Research Management, was recently selected as a Top Ten Woman Business Owner of Northeast Ohio for 2010 by The National Association of Women Business Owners of Cleveland (NAWBO). The NAWBO honors women business owners who have demonstrated excellence as a woman business owner, through initiative and creativity, professional accomplishments, contributions, and community involvement. Victoria was nominated by Kristi Kubiak of First Merit Bank in Hinckley. Victoria served our country in the U.S. Peace Corps in Togo, West Africa in the field of infectious disease control. While there, she experienced first-hand the devastating conditions that people of third world countries endure. She contracted malaria several times and came back to the U.S. with a strong motivation and commitment to spend her life working towards the goal of providing treatments for diseases around the globe. Thus, Clinical Research Management (CRM) was born. CRM is a full service Contract Research Organization that supports the development of FDA-regulated vaccines, pharmaceuticals, and medical devices for both government and commercial customers. Visit our website at www.clinicalrm.com. CRM wishes to thank NAWBO for this honor and for providing women business owners a forum to address their needs and interests. The Top Ten winners will be honored at a gala dinner on Wednesday, April 21st at Landerhaven in Northeast Ohio.

Sachin Mani, Ph.D. RAC Joins CRM

Sachin Mani, Ph.D., RAC has joined CRM as a Program Manager and the Regulatory Section head. In addition to his primary role of overseeing CRM’s research support services contracts at Walter Reed Army Institute of Research, he is also involved in biomedical leadership, business diversification / development and strategic planning initiatives at CRM. He has extensive biomedical R&D, project/program management and regulatory experience. Prior to joining CRM, Sachin was a group leader at MedImmune LLC, a subsidiary of AstraZeneca, where he successfully led two viral vaccine development programs – a) the Madin Darby Canine Kidney (MDCK) vaccine cell substrate characterization program, the chosen cell substrate for MedImmune’s cell culture-based pandemic and seasonal influenza vaccine & b) a bioanalytical assay development program for developing analytical immunoassays for pediatric respiratory viral vaccines. During his tenure at MedImmune, Sachin was also involved in managing preclinical animal studies for respiratory viral vaccines with particular reference to regulatory safety issues. Prior to MedImmune, Sachin was a principal investigator at the Walter Reed Army Institute of Research, where he was instrumental in developing animal model systems for infectious disease pathogens and biological toxins; and in biomarker discovery using genomic and proteomic profiling. Sachin received his Ph.D. in Microbiology (Immunology) at Clemson University. He has authored several publications in the fields of viral vaccine development, infectious disease, immunology and animal model development.

CRM Joins the Association of Clinical Research Organizations

Clinical Research Management, Inc. has joined the Association of Clinical Research Organizations (ACRO) as an Associate Member. CRM is pleased to join with other members such as Covance, Kendle, MDS Pharma Services, Parexel, Pharmanet Development Group, PPD, Quintiles, RPS, Global Research Services, ICON, and PRA International. ACRO represents companies whose focus is clinical research. The Association provides an active voice for the global CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 70,000 professionals worldwide and last year conducted more than 9,000 clinical trials involving nearly 2 million participants in 115 countries.

Jere Boyer M. Boyer, Ph.D. Accepts Position as an Editor of the Manuscript Editing Committee (MEC) for the Navy Medical Journal

Scientific Director of CRM Jere Boyer Jere Boyer, Ph.D., Scientific Director of CRM will assume the position as an Editor for the Manuscript Editing Committee (MEC) of the Navy Medicine Journal (NMJ). The Manuscript Editing Committee of the Navy Medicine Journal is comprised thus far with 90 pro bono professional members from around the world. MEC members provide the actual editing of manuscripts submitted for potential publication in the new publication, "Healthcare, Science, and the Medical Humanities: The Navy Medicine Journal." The Journal is published by Navy Medicine under the new Navy Medicine Institute for the Medical Humanities and Research Leadership. NMJ will begin publishing in 2011.

Sue Chase Accepts the Position of Chief Operating Officer of CRM

Chief Operating Officer and Director of Clinical Solutions Sue Chase

Sue Chase is the Chief Operating Officer and Director of Clinical Solutions of CRM. She leads business development, strategic planning, development and implementation of global clinical operations and strategies, marketing, and administrative operations. She has over 26 years experience in healthcare arena and 22 years experience in upper management in a clinical research environment of which she spent 10 years as Director of the Cleveland Clinic Cardiovascular Coordinating Center (C5), an Academic Research Organization at the Cleveland Clinic. She is expected to play a major role in moving CRM forward “To be a leader in the Biomedical/CRO industry within the next 5 years.” Ms. Chase received her B.S.N. from The University of Akron.